Levels of IL-32 in Serum, Induced Sputum Supernatant, and Bronchial Lavage Fluid of Patients with Chronic Obstructive Pulmonary Disease

References

• Barnes PJ. Chronic obstructive pulmonary disease: A growing but neglected global epidemic. PLoS Med 2007; 4(5):e112.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Buist AS. Global burden of COPD: Risk factors, prevalence, and future trends. Lancet 2007; 370(9589):765–773.
   PubMed Web of Science ®Google Scholar
• Pearce N, Ait-Khaled N, Beasley R, Mallol J, Keil U, Mitchell E, et al. Worldwide trends in the prevalence of asthma symptoms: Phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2007; 62(9):758–766.
   PubMed Web of Science ®Google Scholar
• Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and a meta-analysis. Thorax 2004; 59(7):574–580.
   PubMed Web of Science ®Google Scholar
• Cockayne DA, Cheng DT, Waschki B, Sridhar S, Ravindran P, Hilton H, et al. Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severity. PloS One 2012; 7(6):e38629.
   PubMed Web of Science ®Google Scholar
• Barbu C, Iordache M, Man MG. Inflammation in COPD: Pathogenesis, local and systemic effects. Rom J Morphol Embryol 2011; 52(1):21–27.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Clin Chest Med 2014; 35(1):71–86.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000; 161(5):1720–1745.
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, Committee GS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163(5):1256–1276.
   PubMedGoogle Scholar
• Rom O, Avezov K, Aizenbud D, Reznick AZ. Cigarette smoking and inflammation revisited. Respir Physiol Neurobiol. 2013; 187(1):5–10.
   PubMed Web of Science ®Google Scholar
• Pelegrino NR, Tanni SE, Amaral RA, Angeleli AY, Correa C, Godoy I. Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease. Am J Med Sci. 2013; 345(6):440–445.
   PubMed Web of Science ®Google Scholar
• Siroux V, Pin I, Oryszczyn MP, Le Moual N, Kauffmann F. Relationships of active smoking to asthma and asthma severity in the EGEA study. Epidemiological study on the Genetics and Environment of Asthma. Eur Respir J 2000; 15(3):470–477.
   Google Scholar
• Shaykhiev R, Crystal RG. Innate immunity and chronic obstructive pulmonary disease: A mini-review. Gerontology 2013; 59(6):481–489.
   PubMed Web of Science ®Google Scholar
• Deckers J, Branco Madeira F, Hammad H. Innate immune cells in asthma. Trends Immunol 2013; 34(11):540–547.
   PubMed Web of Science ®Google Scholar
• Hart LA, Krishnan VL, Adcock IM, Barnes PJ, Chung KF. Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. Am J Respir Crit Care Med 1998; 158(5 Pt 1):1585–1592.
   PubMed Web of Science ®Google Scholar
• Caramori G, Romagnoli M, Casolari P, Bellettato C, Casoni G, Boschetto P, et al. Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations. Thorax 2003; 58(4):348–351.
   PubMed Web of Science ®Google Scholar
• Kudo M, Ogawa E, Kinose D, Haruna A, Takahashi T, Tanabe N, et al. Oxidative stress induced interleukin-32 mRNA expression in human bronchial epithelial cells. Respir Res 2012; 13:19.
   PubMed Web of Science ®Google Scholar
• Hong J, Bae S, Kang Y, Yoon D, Bai X, Chan ED, et al. Suppressing IL-32 in monocytes impairs the induction of the proinflammatory cytokines TNFalpha and IL-1beta. Cytokine 2010; 49(2):171–176.
   PubMed Web of Science ®Google Scholar
• Meyer N, Zimmermann M, Burgler S, Bassin C, Woehrl S, Moritz K, et al. IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. J Allergy Clin Immunol 2010; 125(4):858–865e10.
   PubMed Web of Science ®Google Scholar
• Dinarello CA, Kim SH. IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis 2006; 65 Suppl 3:iii61–64.
   PubMedGoogle Scholar
• Calabrese F, Baraldo S, Bazzan E, Lunardi F, Rea F, Maestrelli P, et al. IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 178(9):894–901.
   PubMed Web of Science ®Google Scholar
• Deng X, Zhang Z, Gu W, Li Y, Liu M. Budesonide inhibits interleukin-32 expression in a rat model of chronic obstructive pulmonary disease. Exp Lung Res 2012; 38(6):295–301.
   PubMed Web of Science ®Google Scholar
• Alsaleh G, Sparsa L, Chatelus E, Ehlinger M, Gottenberg JE, Wachsmann D, et al. Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther 2010; 12(4):R135.
   PubMed Web of Science ®Google Scholar
• Keswani A, Chustz RT, Suh L, Carter R, Peters AT, Tan BK, et al. Differential expression of interleukin-32 in chronic rhinosinusitis with and without nasal polyps. Allergy 2012; 67(1):25–32.
   PubMed Web of Science ®Google Scholar
• Soyka MB, Treis A, Eiwegger T, Menz G, Zhang S, Holzmann D, et al. Regulation and expression of IL-32 in chronic rhinosinusitis. Allergy 2012; 67(6):790–798.
   PubMed Web of Science ®Google Scholar
• Jeong HJ, Shin SY, Oh HA, Kim MH, Cho JS, Kim HM. IL-32 up-regulation is associated with inflammatory cytokine production in allergic rhinitis. J Pathol 2011; 224(4):553–563.
   PubMed Web of Science ®Google Scholar
• Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31(1):143–178.
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. Multi-ethnic reference values for spirometry for the 3–95-year age range: The global lung function 2012 equations. Eur Respir J 2012; 40(6):1324–1343.
   PubMed Web of Science ®Google Scholar
• Babusyte A, Stravinskaite K, Jeroch J, Lotvall J, Sakalauskas R, Sitkauskiene B. Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD. Respir Res 2007; 8:81.
   PubMed Web of Science ®Google Scholar
• Kheradmand F, Shan M, Xu C, Corry DB. Autoimmunity in chronic obstructive pulmonary disease: Clinical and experimental evidence. Expert Rev Clin Immunol 2012; 8(3):285–292.
   PubMed Web of Science ®Google Scholar
• Du Y, Wang W, Yang W, He B. Interleukin-32, not reduced by salmeterol/fluticasone propionate in smokers with chronic obstructive pulmonary disease. Chinese Med J-Peking 2014; 127(9):1613–1618.
   PubMed Web of Science ®Google Scholar
• Koutsokera A, Kostikas K, Nicod LP, Fitting JW. Pulmonary biomarkers in COPD exacerbations: A systematic review. Respir Res 2013; 14:111.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008; 8(3):183–192.
   PubMed Web of Science ®Google Scholar
• Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA. Interleukin-32: A cytokine and inducer of TNFalpha. Immunity 2005; 22(1):131–142.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest 2008; 118(11):3546–3556.
   PubMed Web of Science ®Google Scholar
• Fahy JV, Boushey HA, Lazarus SC, Mauger EA, Cherniack RM, Chinchilli VM, et al. Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med 2001; 163(6):1470–1475.
   PubMed Web of Science ®Google Scholar
• Paggiaro PL, Chanez P, Holz O, Ind PW, Djukanovic R, Maestrelli P, et al. Sputum induction. Eur Respir J Suppl 2002; 37:3s–8s.
   PubMedGoogle Scholar
• Kips JC, Fahy JV, Hargreave FE, Ind PW, in't Veen JC. Methods for sputum induction and analysis of induced sputum: A method for assessing airway inflammation in asthma. Eur Respir J Suppl 1998; 26:9S–12S.
   PubMedGoogle Scholar
• Keatings VM, Evans DJ, O'Connor BJ, Barnes PJ. Cellular profiles in asthmatic airways: A comparison of induced sputum, bronchial washings, and bronchoalveolar lavage fluid. Thorax 1997; 52(4):372–374.
   PubMed Web of Science ®Google Scholar
• Greene CM, Low TB, O'Neill SJ, McElvaney NG. Anti-proline-glycine-proline or antielastin autoantibodies are not evident in chronic inflammatory lung disease. Am J Respir Crit Care Med 2010; 181(1):31–35.
   PubMed Web of Science ®Google Scholar
• Meyer N, Christoph J, Makrinioti H, Indermitte P, Rhyner C, Soyka M, et al. Inhibition of angiogenesis by IL-32: Possible role in asthma. J Allergy Clin Immunol 2012; 129(4):964–973e7.
   PubMed Web of Science ®Google Scholar
• Lotvall J, Akdis CA, Bacharier LB, Bjermer L, Casale TB, Custovic A, et al. Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol 2011; 127(2):355–360.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Mechanisms in COPD: Differences from asthma. Chest 2000; 117(2 Suppl):10 S–14 S.
   Google Scholar
• Hacievliyagil SS, Mutlu LC, Temel I. Airway inflammatory markers in chronic obstructive pulmonary disease patients and healthy smokers. Niger J Clin Pract 2013; 16(1):76–81.
   PubMed Web of Science ®Google Scholar
• Netea MG, Azam T, Lewis EC, Joosten LA, Wang M, Langenberg D, et al. Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanism. PLoS Med 2006; 3(8):e277.
   PubMedGoogle Scholar
• Peters-Golden M. The alveolar macrophage: The forgotten cell in asthma. Am J Respir Cell Mol Biol 2004; 31(1):3–7.
   PubMed Web of Science ®Google Scholar
• Balbi B, Pignatti P, Corradi M, Baiardi P, Bianchi L, Brunetti G, et al. Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults. Eur Respir J 2007; 30(4):769–781.
   PubMed Web of Science ®Google Scholar
• Sabroe I, Parker LC, Calverley PM, Dower SK, Whyte MK. Pathological networking: A new approach to understanding COPD. Postgrad Med J 2008; 84(991):259–264.
   PubMed Web of Science ®Google Scholar
• Rong Y, Xiang XD, Li YM, Peng ZY, Li JX. IL-32 was involved in cigarette smoke-induced pulmonary inflammation in COPD. Clin Respir J 2014. doi:10.1111/crj.12157. [Epub ahead of print]
   Web of Science ®Google Scholar